Pharma Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Australian cGMP manufacturing facility opened
August 15th, 2005
Invitrogen Corporation (IVGN), a provider of essential life science technologies for disease research and drug discovery, announced the opening of a new cGMP bioproduction facility focused on development of safe and consistent bovine sera products and reagents used in basic research and the production of vaccines and biotherapeutic drugs for world markets. The 1,000 square meter facility, located in New South Wales, was first announced in August of 2004 as part of an ongoing expansion of Invitrogen's Australian operations. "While the industry is transitioning to advanced media and animal-free products, there is still a need to support researchers...
Source: Pharma Business Week (2005-08-15)
|
